Investigators tested the accuracy of the EndoFaster® device in performing gastric juice analysis, with the goal of reducing the need for gastric biopsies in the detection of H pylori.
Researchers assessed the effects of different H pylori infections on distribution of histopathological characteristics and items of serum gastric function.
A team of investigators conducted a multicenter, randomized, controlled trial to identify factors related to the eradication of H pylori with dual vonoprazan and amoxicillin as first-line therapy.
A team of investigators sought to determine factors that affect the success of second-line therapy using vonoprazan, a gastric acid secretion inhibitor that improves the success rate of Helicobacter pylori eradication.
The American Gastroenterological Association issued a clinical practice update to provide clinicians with practical advice on how to manage patients for whom initial treatment for H pylori infection was unsuccessful.
Investigators performed a cross-sectional study to assess reflux esophagitis in patients having undergone successful eradication of Helicobacter pylori infection.
A team of investigators conducted a large retrospective, cohort study to assess whether a longitudinal link exists between H pylori infection and the risk of developing dyslipidemia.
A team of investigators explored the ability of different machine learning models to predict the risk of gastric cancer development in patients who had undergone eradication of Helicobacter pylori infection.
The researchers’ goal was to determine which dimensions of smoking increase the risk for gastric intestinal metaplasia, which is a precursor lesion of gastric cancer.
Improving treatment in H pylori infection could lead to better outcomes in peptic ulcer disease, gastric cancer, gastric lymphoma, and functional dyspepsia.
A team of investigators created a deep learning-based decision support algorithm to identify the presence of Helicobacter pylori in gastric biopsy specimens.
A team of investigators conducted a study to determine the effectiveness of 2 new stool-based enzyme-linked assays to identify the presence of H pylori antigen.
A global consensus meeting was convened to go over current evidence and knowledge gaps and propose collaborative studies on population-wide screening and eradication of Helicobacter pylori for the prevention of gastric cancer (GC).
